Gut microbiota composition as a candidate risk factor for dimethyl fumarate-induced lymphopenia in multiple sclerosis

Mounting evidence points towards a pivotal role of gut microbiota in multiple sclerosis (MS) pathophysiology. Yet, whether disease-modifying treatments alter microbiota composition and whether microbiota shape treatment response and side-effects remain unclear. In this prospective observational pilo...

Descripción completa

Detalles Bibliográficos
Autores principales: Diebold, Martin, Meola, Marco, Purushothaman, Srinithi, Siewert, Lena K, Pössnecker, Elisabeth, Roloff, Tim, Lindberg, Raija LP, Kuhle, Jens, Kappos, Ludwig, Derfuss, Tobias, Egli, Adrian, Pröbstel, Anne-Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677991/
https://www.ncbi.nlm.nih.gov/pubmed/36398902
http://dx.doi.org/10.1080/19490976.2022.2147055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677991/
https://www.ncbi.nlm.nih.gov/pubmed/36398902
http://dx.doi.org/10.1080/19490976.2022.2147055

Ejemplares similares